@tell.a.story48: Weight-loss jabs help control asthma in obese patients jabs could help obese people better control their asthma symptoms, according to new research. The drugs should be explored as a potential treatment for obese patients with the respiratory condition, who are "often resistant" to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicking the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes#goviral #medical #healthy #healthylifestyle #fyp